Related Experiment Video
Updated: Jun 9, 2025

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
Published on: November 7, 2012
Examination of yield, bacteriolytic activity and cold storage of linker deletion mutants based on endolysin S6_ORF93
Sosuke Munetomo1, Jumpei Uchiyama2, Iyo Takemura-Uchiyama2
1Department of Public Health, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan.
Abstract:
Methicillin-resistant Staphylococcus spp. present challenges in clinical and veterinary settings because effective antimicrobial agents are limited. Phage-encoded peptidoglycan-degrading enzyme, endolysin, is expected to be a novel antimicrobial agent. The enzymatic activity has recently been shown to be influenced by the linker between functional domains in the enzyme. S6_ORF93 (ORF93) is one of the endolysins derived from previously isolated Staphylococcus giant phage S6. The ORF93 was speculated to have a catalytic and peptidoglycan-binding domain with a long linker. In this study, we examined the influence of linker shortening on the characteristics of ORF93. We produce wild-type ORF93 and the linker deletion mutants using an Escherichia coli expression system. These mutants were designated as ORF93-Δ05, ORF93-Δ10, ORF93-Δ15, and ORF93-Δ20, from which 5, 10, 15, and 20 amino acids were removed from the linker, respectively. Except for the ORF93-Δ20, ORF93 and its mutants were expressed as soluble proteins. Moreover, ORF93-Δ15 showed the highest yield and bacteriolytic activity, while the antimicrobial spectrum was homologous. The cold storage experiment showed a slight effect by the linker deletion. According to our results and other studies, linker investigations are crucial in endolysin development.
Insights
Shortening the linker in Staphylococcus endolysin ORF93 enhanced its bacteriolytic activity and protein yield. This research highlights linker optimization for developing novel antimicrobial agents against resistant bacteria.
Area of Science:
- Microbiology
- Biochemistry
- Antimicrobial Research
Background:
- Methicillin-resistant Staphylococcus species pose significant clinical and veterinary challenges due to limited effective treatments.
- Phage-derived endolysins are promising antimicrobial agents, with their activity potentially modulated by linker regions.
- Staphylococcus phage S6 endolysin S6_ORF93 (ORF93) was hypothesized to possess a catalytic domain, a peptidoglycan-binding domain, and a long linker.
Purpose of the Study:
- To investigate the impact of linker length reduction on the biochemical properties and lytic activity of the Staphylococcus endolysin ORF93.
- To engineer and characterize ORF93 linker deletion mutants for potential therapeutic applications.
Main Methods:
- Wild-type ORF93 and four linker deletion mutants (ORF93-Δ05, ORF93-Δ10, ORF93-Δ15, ORF93-Δ20) were produced in an Escherichia coli expression system.
- Solubility, protein yield, bacteriolytic activity, antimicrobial spectrum, and stability under cold storage were assessed for each variant.
Main Results:
- Most mutants, except ORF93-Δ20, were successfully expressed as soluble proteins.
- ORF93-Δ15 exhibited the highest protein yield and significant bacteriolytic activity against Staphylococcus strains.
- The antimicrobial spectrum remained consistent across the tested variants, and linker deletion had a minimal effect on cold storage stability.
Conclusions:
- Linker length is a critical factor in optimizing the efficacy of endolysin ORF93 as an antimicrobial agent.
- The ORF93-Δ15 mutant demonstrates potential as a novel therapeutic candidate for combating Staphylococcus infections.
- Further investigation into endolysin linker engineering is essential for developing effective phage-based antimicrobials.
Related Concept Videos
Viral Replication: Lysogenic Cycle
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages

